Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 12;211(5):729-736.
doi: 10.1164/rccm.202407-1379CI. Online ahead of print.

Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to Therapy

Affiliations

Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to Therapy

Bartolome R Celli et al. Am J Respir Crit Care Med. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition of the lungs, characterized by chronic respiratory symptoms, primarily dyspnea, cough, and sputum production, due to airway and/or alveoli abnormalities that cause persistent, and often progressive, airflow obstruction. Although the underlying mechanisms responsible for COPD remain poorly understood, over the last several decades, clinical phenotypes and endotypes have been suggested. These include frequent exacerbator and eosinophilic groups that guide tailored therapies for patients with that clinical expression. In the developed world, smoking is the main known cause of COPD, responsible for ~80% of cases. Active smokers have more severe disease, with more rapid lung function decline and impaired quality of life, than former smokers. Unfortunately, smoking is still highly prevalent. Rates range between 3% and 37% globally, with factors including sex, age, race, education level, and geography influencing the rate of addiction. Importantly, several studies have shown that smoking detrimentally affects treatment efficacy of COPD medications; this is particularly true of inhaled corticosteroids and macrolides. In this review, we discuss the effects of smoking on the pathophysiology of COPD and the clinical impact of smoke exposure in patients with COPD. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Keywords: COPD; clinical phenotypes; endotypes; smoking.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phenotypes and inflammatory endotypes of chronic obstructive pulmonary disease (COPD). *Global Initiative for Chronic Obstructive Lung Disease guidelines no longer recognize asthma–COPD overlap syndrome and instead emphasize that asthma and COPD are two separate diseases (1).
Figure 2.
Figure 2.
The role of smoking status as a phenotype in COPD. COPD = chronic obstructive pulmonary disease; ICS = inhaled corticosteroid.

References

    1. Global Initiative for Chronic Obstructive Lung Disease. Global Initiative for Chronic Obstructive Lung Disease; 2022. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.https://goldcopd.org/wp-content/uploads/2022/12/GOLD-2023-ver-1.1-2Dec20...
    1. Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med . 2019;381:1257–1266. - PubMed
    1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 1995;152:S77–S121. - PubMed
    1. Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep . 2018;67:53–59. - PMC - PubMed
    1. World Health Organization. 4th ed. Geneva, Switzerland: World Health Organization; 2021. https://www.who.int/publications/i/item/9789240039322

LinkOut - more resources